Ursula Matulonis, M.D., Dana-Farber Cancer Institute (IMAGE)

Dana-Farber Cancer Institute

Ursula Matulonis, M.D., Dana-Farber Cancer Institute

Caption

Ursula Matulonis, M.D., and colleagues say the technique used to identify a new subtype of ovarian cancer may prove useful in determining how a patient's cancer might respond to a specific treatments.

Credit

Sam Ogden

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.